AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
Roche posts IMpower010 results in resected NSCLC; adds polatuzumab real-world studySep 30Weekly roundup, 9 itemsafimkibartatezolizumabUpdated
Nanobiotix updates on JNJ-1900 (NBTXR3) trials, FDA-cleared protocol change, and cash into 2029Sep 24Quarterly updateNanobiotix S.A.
Fennec reports Phase 2 PEDMARK data from Japan met primary endpoint at SIOP 2026Sep 17Clinical readoutFennec Pharmaceuticals Inc.sodium thiosulfate
Incyte-backed trials: OSU tests pemigatinib cycling regimen; OHSU starts Opzelura pilot for PGAug 24Weekly roundup, 2 itemsIncyte Corporationpemigatinib
Incyte-linked filings this week: FIGHT-302 results posted, new academic pancreatic trial listedAug 14Weekly roundup, 2 itemsIncyte Corporationpemigatinib
Merck posts Q2 loss on Terns charge, raises full-year sales outlookAug 4Quarterly updateMerck & Co., Inc.
Bicycle Therapeutics reports Q2 2026 pipeline progress, cash into 2030Jul 30Quarterly updateBicycle Therapeutics Plc
Molecular Partners reports progress in Phase 2 TACTIC trial of MP0317 for cholangiocarcinomaJul 20Clinical readoutMolecular Partners AG
BMS posts PRIME-HCC results; adds SOTYKTU label update, Phase 3 lung trialJul 2Weekly roundup, 7 itemsBristol Myers Squibbcisplatin
Sign inSign in